Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2026-01-28 @ 1:14 PM
Study NCT ID:
NCT07024550
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-07-18
First Post:
2025-06-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Impact of the EXOMIND (BTL-699-2) on the Brain Reward Pathway
Sponsor:
BTL Industries Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BTL-699_CTCZ200
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None